Repatriated Funds Should Not Be Used For Liability Costs – Congressman
This article was originally published in The Tan Sheet
Executive Summary
The U.S. Treasury Department should clarify that pharmaceutical companies cannot use the tax repatriation provision of a recently enacted jobs bill to cover tort and liability expenses, House Ways & Means Health Subcommittee Ranking Member Pete Stark (D-Calif.) maintains
You may also be interested in...
Pharma Firms Ready To Repatriate Billions Once “JOBS” Bill Is Signed
J&J intends to repatriate as much as $10 bil. held by foreign subsidiaries following President Bush's expected signing of the "JOBS" bill
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands